Zevalin and Deep venous thrombosis - a phase IV clinical study of FDA data

Summary:

Deep venous thrombosis is reported as a side effect among people who take Zevalin (ibritumomab tiuxetan), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Bendamustine, and have Non-hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Deep venous thrombosis when taking Zevalin. It is created by eHealthMe based on reports of 2,256 people who have side effects when taking Zevalin from the FDA, and is updated regularly.

What is Zevalin?

Zevalin has active ingredients of ibritumomab tiuxetan. eHealthMe is studying from 2,258 Zevalin users. Check the latest studies of Zevalin.

What is Deep venous thrombosis?

Deep venous thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis) is found to be associated with 2,069 drugs and 2,965 conditions by eHealthMe. Check the latest studies of Deep venous thrombosis.

On Jul, 09, 2026

2,256 people reported to have side effects when taking Zevalin.
Among them, 15 people (0.66%) have Deep venous thrombosis.

Could Zevalin cause Deep venous thrombosis?

Among these 15 people:

How long have people been on Zevalin when they have Deep venous thrombosis? *

What is the gender of people who have Deep venous thrombosis when taking Zevalin? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Deep venous thrombosis when taking Zevalin? *

What are other drugs people take besides Zevalin? *

What are other side effects people have besides Deep venous thrombosis? *

Weight Decreased: 6 people, 40.00%
Pneumonia Influenzal (the flu with pneumonia): 6 people, 40.00%
Dyspnea (difficult or laboured breathing): 6 people, 40.00%
High Blood Pressure: 6 people, 40.00%
Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 6 people, 40.00%
Indigestion: 6 people, 40.00%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 6 people, 40.00%
Mitral Valve Incompetence (inefficient heart valve): 6 people, 40.00%
Cardiomyopathy (weakening of the heart muscle): 6 people, 40.00%
Oesophageal Candidiasis (fungal infection of oesophagus): 6 people, 40.00%

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 10 people, 66.67%
Burkitt Lymphoma (cancer of the lymphatic system): 6 people, 40.00%
Lymphoma (cancer that begins in immune system cells): 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zevalin and have Deep venous thrombosis?

- Check whether Deep venous thrombosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zevalin:

Zevalin (2,258 reports)

Browse all side effects of Zevalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,069 drugs)

Browse all the conditions that are associated with Deep venous thrombosis:

Deep venous thrombosis (2,965 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ibritumomab tiuxetan (the active ingredients of Zevalin) and Zevalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.